Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients

Update: 2023-05-09

Description

Rick Greene, MD, discusses with Julie Culver, MS, LCGC, CCRP, the implementation of genetic testing for all patients with breast cancer and how this can be incorporated into oncology care. Ms. Culver is author of "Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients."

Julie Culver is the Director of Genetic Counseling at the USC Norris Cancer Hospital and is a Clinical Instructor of Medicine at the USC Keck School of Medicine, Los Angeles, CA.

http://doi.org/10.1245/S10434-022-12595-W

Comments

In Channel

ASO Series: Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody

2024-12-1016:43

ASO Series: A Four-Arm Randomized Clinical Trial of Topical Pain Control for Sentinel Node Radiotracer Injections in Patients with Breast Cancer

2024-11-1914:18

Adjuvant Chemoradiation in Resected Biliary Adenocarcinoma: Evaluation of SWOG S0809 with a Large National Database

2024-10-0812:47

SSO2024 Abstract: Lower Social Support Predicts Higher Cortisol for Breast Cancer Patients in Disadvantaged Neighborhoods

2024-09-1015:45

Practice Patterns and Outcomes Among Surgical Oncology Fellowship Graduates Performing Complex Cancer Surgery in the United States Across Different Career Stages

2024-08-1319:44

Extent of Resection and Long-Term Outcomes for Appendiceal Adenocarcinoma: a SEER Database Analysis of Mucinous and non-Mucinous Histologies

2024-07-1614:33

Docetaxel‑Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15‑Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer Network

2024-06-1117:34

The Landmark Series—Addressing Disparities in Breast Cancer Screening: New Recommendations for Black Women

2024-05-2114:34

Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6

2024-04-0916:59

Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer

2024-03-1220:49

Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic Cancer. Do They Matter?

2024-02-1317:42

Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study

2024-01-0917:17

CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer

2023-12-1215:33

Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients

2023-11-1416:08

Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects

2023-10-1017:08

Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer

2023-09-1215:02

Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center

2023-08-0814:29

Exploring the Potential of Artificial Intelligence in Surgery: Insights from a Conversation with ChatGPT

2023-07-1116:45

A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases

2023-06-1312:03

Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients

2023-05-0917:35

00:00

Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients

Annals of Surgical Oncology

#box-pro-ellipsis-176445052864788{-webkit-line-clamp:2;}Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients

Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients

Annals of Surgical Oncology

Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients